Esperion Therapeutics (ESPR) PT Lowered to $40 at Jefferies
Tweet
Share
E-mailGet Alerts ESPR Hot Sheet
Price: $3.18 --0%
Rating Summary:
6 Buy, 14 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 4 | Down: 16 | New: 11
Rating Summary:
6 Buy, 14 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 4 | Down: 16 | New: 11
Join SI Premium – FREE
Jefferies analyst Michael Yee lowered the price target on Esperion Therapeutics (NASDAQ: ESPR) to $40.00 (from $53.00) while maintaining a Buy rating.
You May Also Be Interested In
- MongoDB (MDB) PT Raised to $465 at DA Davidson Ahead of Q2 Results
- nCino Inc. (NCNO) PT Raised to $20 at Truist Securities
- nCino Inc. (NCNO) PT Raised to $25 at Keefe, Bruyette & Woods
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
